1 Min Read
Dec 28 (Reuters) - Immunoprecise Antibodies Ltd:
* IMMUNOPRECISE ANTIBODIES - WILL BUY ALL ISSUED AND OUTSTANDING SHARES OF PRECLINICS FOR EUR 2.3 MILLION Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.